PDE5 inhibitors enhance the lethality of standard of care chemotherapy in pediatric CNS tumor cells

References

• Alexiou GA, Vartholomatos G, Stefanaki K, Patereli A, Dova L, Karamoutsios A, Lallas G, Sfakianos G, Moschovi M, Prodromou N. Expression of heat shock proteins in medulloblastoma. J Neurosurg Pediatr 2013; 12:452 - 7; http://dx.doi.org/10.3171/2013.7.PEDS1376; PMID: 23992239
   PubMed Web of Science ®Google Scholar
• De Braganca KC, Packer RJ. Treatment Options for Medulloblastoma and CNS Primitive Neuroectodermal Tumor (PNET). Curr Treat Options Neurol 2013; 15:593 - 606; http://dx.doi.org/10.1007/s11940-013-0255-4; PMID: 23979905
   PubMed Web of Science ®Google Scholar
• American Cancer Society. Cancer Facts and Figures 2013. Atlanta, Ga: American Cancer Society, 2013. Available online.
   Google Scholar
• Bender AT, Beavo JA. Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use. Pharmacol Rev 2006; 58:488 - 520; http://dx.doi.org/10.1124/pr.58.3.5; PMID: 16968949
   PubMed Web of Science ®Google Scholar
• Das A, Ockaili R, Salloum F, Kukreja RC. Protein kinase C plays an essential role in sildenafil-induced cardioprotection in rabbits. Am J Physiol Heart Circ Physiol 2004; 286:H1455 - 60; http://dx.doi.org/10.1152/ajpheart.01040.2003; PMID: 15020304
   PubMed Web of Science ®Google Scholar
• Das A, Xi L, Kukreja RC. Phosphodiesterase-5 inhibitor sildenafil preconditions adult cardiac myocytes against necrosis and apoptosis. Essential role of nitric oxide signaling. J Biol Chem 2005; 280:12944 - 55; http://dx.doi.org/10.1074/jbc.M404706200; PMID: 15668244
   PubMed Web of Science ®Google Scholar
• Das A, Salloum FN, Xi L, Rao YJ, Kukreja RC. ERK phosphorylation mediates sildenafil-induced myocardial protection against ischemia-reperfusion injury in mice. Am J Physiol Heart Circ Physiol 2009; 296:H1236 - 43; http://dx.doi.org/10.1152/ajpheart.00100.2009; PMID: 19286961
   PubMed Web of Science ®Google Scholar
• Das A, Xi L, Kukreja RC. Protein kinase G-dependent cardioprotective mechanism of phosphodiesterase-5 inhibition involves phosphorylation of ERK and GSK3beta. J Biol Chem 2008; 283:29572 - 85; http://dx.doi.org/10.1074/jbc.M801547200; PMID: 18723505
   PubMed Web of Science ®Google Scholar
• Ockaili R, Salloum F, Hawkins J, Kukreja RC. Sildenafil (Viagra) induces powerful cardioprotective effect via opening of mitochondrial K(ATP) channels in rabbits. Am J Physiol Heart Circ Physiol 2002; 283:H1263 - 9; PMID: 12181158
   PubMed Web of Science ®Google Scholar
• Salloum FN, Abbate A, Das A, Houser JE, Mudrick CA, Qureshi IZ, Hoke NN, Roy SK, Brown WR, Prabhakar S, et al. Sildenafil (Viagra) attenuates ischemic cardiomyopathy and improves left ventricular function in mice. Am J Physiol Heart Circ Physiol 2008; 294:H1398 - 406; http://dx.doi.org/10.1152/ajpheart.91438.2007; PMID: 18223185
   PubMed Web of Science ®Google Scholar
• Salloum F, Yin C, Xi L, Kukreja RC. Sildenafil induces delayed preconditioning through inducible nitric oxide synthase-dependent pathway in mouse heart. Circ Res 2003; 92:595 - 7; http://dx.doi.org/10.1161/01.RES.0000066853.09821.98; PMID: 12637371
   PubMed Web of Science ®Google Scholar
• Salloum FN, Ockaili RA, Wittkamp M, Marwaha VR, Kukreja RC. Vardenafil: a novel type 5 phosphodiesterase inhibitor reduces myocardial infarct size following ischemia/reperfusion injury via opening of mitochondrial K(ATP) channels in rabbits. J Mol Cell Cardiol 2006; 40:405 - 11; http://dx.doi.org/10.1016/j.yjmcc.2005.10.002; PMID: 16480739
   PubMed Web of Science ®Google Scholar
• Fisher PW, Salloum F, Das A, Hyder H, Kukreja RC. Phosphodiesterase-5 inhibition with sildenafil attenuates cardiomyocyte apoptosis and left ventricular dysfunction in a chronic model of doxorubicin cardiotoxicity. Circulation 2005; 111:1601 - 10; http://dx.doi.org/10.1161/01.CIR.0000160359.49478.C2; PMID: 15811867
   PubMed Web of Science ®Google Scholar
• Karami-Tehrani F, Moeinifard M, Aghaei M, Atri M. Evaluation of PDE5 and PDE9 expression in benign and malignant breast tumors. Arch Med Res 2012; 43:470 - 5; http://dx.doi.org/10.1016/j.arcmed.2012.08.006; PMID: 22960860
   PubMed Web of Science ®Google Scholar
• Eggen T, Sager G, Berg T, Nergaard B, Moe BT, Ørbo A. Increased gene expression of the ABCC5 transporter without distinct changes in the expression of PDE5 in human cervical cancer cells during growth. Anticancer Res 2012; 32:3055 - 61; PMID: 22843873
   PubMed Web of Science ®Google Scholar
• Zhang X, Yan G, Ji J, Wu J, Sun X, Shen J, Jiang H, Wang H. PDE5 inhibitor promotes melanin synthesis through the PKG pathway in B16 melanoma cells. J Cell Biochem 2012; 113:2738 - 43; http://dx.doi.org/10.1002/jcb.24147; PMID: 22441938
   PubMed Web of Science ®Google Scholar
• Sarfati M, Mateo V, Baudet S, Rubio M, Fernandez C, Davi F, Binet JL, Delic J, Merle-Beral H. Sildenafil and vardenafil, types 5 and 6 phosphodiesterase inhibitors, induce caspase-dependent apoptosis of B-chronic lymphocytic leukemia cells. Blood 2003; 101:265 - 9; http://dx.doi.org/10.1182/blood-2002-01-0075; PMID: 12393651
   PubMed Web of Science ®Google Scholar
• Chen JJ, Sun YL, Tiwari AK, Xiao ZJ, Sodani K, Yang DH, Vispute SG, Jiang WQ, Chen SD, Chen ZS. PDE5 inhibitors, sildenafil and vardenafil, reverse multidrug resistance by inhibiting the efflux function of multidrug resistance protein 7 (ATP-binding Cassette C10) transporter. Cancer Sci 2012; 103:1531 - 7; http://dx.doi.org/10.1111/j.1349-7006.2012.02328.x; PMID: 22578167
   PubMed Web of Science ®Google Scholar
• Das A, Durrant D, Mitchell C, Mayton E, Hoke NN, Salloum FN, Park MA, Qureshi I, Lee R, Dent P, et al. Sildenafil increases chemotherapeutic efficacy of doxorubicin in prostate cancer and ameliorates cardiac dysfunction. Proc Natl Acad Sci U S A 2010; 107:18202 - 7; http://dx.doi.org/10.1073/pnas.1006965107; PMID: 20884855
   PubMed Web of Science ®Google Scholar
• Zhang Z, Wang CZ, Du GJ, Qi LW, Calway T, He TC, Du W, Yuan CS. Genistein induces G2/M cell cycle arrest and apoptosis via ATM/p53-dependent pathway in human colon cancer cells. Int J Oncol 2013; 43:289 - 96; PMID: 23686257
   PubMed Web of Science ®Google Scholar
• Wang Y, Wang H, Zhang W, Shao C, Xu P, Shi CH, Shi JG, Li YM, Fu Q, Xue W, et al. Genistein sensitizes bladder cancer cells to HCPT treatment in vitro and in vivo via ATM/NF-κB/IKK pathway-induced apoptosis. PLoS One 2013; 8:e50175; http://dx.doi.org/10.1371/journal.pone.0050175; PMID: 23365634
   PubMed Web of Science ®Google Scholar
• Korwek Z, Sewastianik T, Bielak-Zmijewska A, Mosieniak G, Alster O, Moreno-Villanueva M, Burkle A, Sikora E. Inhibition of ATM blocks the etoposide-induced DNA damage response and apoptosis of resting human T cells. DNA Repair (Amst) 2012; 11:864 - 73; http://dx.doi.org/10.1016/j.dnarep.2012.08.006; PMID: 23058634
   PubMed Web of Science ®Google Scholar
• Daugherity EK, Balmus G, Al Saei A, Moore ES, Abi Abdallah D, Rogers AB, Weiss RS, Maurer KJ. The DNA damage checkpoint protein ATM promotes hepatocellular apoptosis and fibrosis in a mouse model of non-alcoholic fatty liver disease. Cell Cycle 2012; 11:1918 - 28; http://dx.doi.org/10.4161/cc.20259; PMID: 22544329
   PubMed Web of Science ®Google Scholar
• Bareford MD, Park MA, Yacoub A, Hamed HA, Tang Y, Cruickshanks N, Eulitt P, Hubbard N, Tye G, Burow ME, et al. Sorafenib enhances pemetrexed cytotoxicity through an autophagy-dependent mechanism in cancer cells. Cancer Res 2011; 71:4955 - 67; http://dx.doi.org/10.1158/0008-5472.CAN-11-0898; PMID: 21622715
   PubMed Web of Science ®Google Scholar
• Cruickshanks N, Tang Y, Booth L, Hamed H, Grant S, Dent P. Lapatinib and obatoclax kill breast cancer cells through reactive oxygen species-dependent endoplasmic reticulum stress. Mol Pharmacol 2012; 82:1217 - 29; http://dx.doi.org/10.1124/mol.112.081539; PMID: 22989520
   PubMed Web of Science ®Google Scholar
• Park MA, Zhang G, Martin AP, Hamed H, Mitchell C, Hylemon PB, Graf M, Rahmani M, Ryan K, Liu X, et al. Vorinostat and sorafenib increase ER stress, autophagy and apoptosis via ceramide-dependent CD95 and PERK activation. Cancer Biol Ther 2008; 7:1648 - 62; http://dx.doi.org/10.4161/cbt.7.10.6623; PMID: 18787411
   PubMed Web of Science ®Google Scholar
• Zhang G, Park MA, Mitchell C, Hamed H, Rahmani M, Martin AP, Curiel DT, Yacoub A, Graf M, Lee R, et al. Vorinostat and sorafenib synergistically kill tumor cells via FLIP suppression and CD95 activation. Clin Cancer Res 2008; 14:5385 - 99; http://dx.doi.org/10.1158/1078-0432.CCR-08-0469; PMID: 18765530
   PubMed Web of Science ®Google Scholar